Advertisement
U.S. Markets open in 8 hrs 28 mins

Faron Pharmaceuticals Oy (FARON.HE)

Helsinki - Helsinki Real Time Price. Currency in EUR
1.9200+0.1240 (+6.90%)
At close: 06:29PM EET
Advertisement
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
0
0
0
0
0
Operating Expense
28,567
28,567
27,426
21,109
16,654
Operating Income
-28,567
-28,567
-27,426
-21,109
-16,654
Net Non Operating Interest Income Expense
-2,383
-2,383
-1,349
-230
-53
Pretax Income
-30,944
-30,944
-28,730
-21,178
-16,934
Tax Provision
0
0
0
16
10
Net Income Common Stockholders
-30,944
-30,944
-28,730
-21,194
-16,944
Diluted NI Available to Com Stockholders
-30,944
-30,944
-28,730
-21,194
-16,944
Basic EPS
-0.49
-0.48
-0.52
-0.42
-0.37
Diluted EPS
-0.49
-0.48
-0.52
-0.42
-0.37
Basic Average Shares
60,105
65,055
55,230
50,724
45,712
Diluted Average Shares
60,105
65,055
55,230
50,724
45,712
Total Operating Income as Reported
-28,568
-28,568
-27,426
-21,108
-16,654
Rent Expense Supplemental
320
320
114
7
-
Total Expenses
28,567
28,567
27,426
21,109
16,654
Net Income from Continuing & Discontinued Operation
-30,944
-30,944
-28,730
-21,194
-16,944
Normalized Income
-30,944
-30,944
-28,730
-21,194
-16,944
Interest Income
230
230
11
2
109
Interest Expense
2,167
2,167
1,373
215
149
Net Interest Income
-2,383
-2,383
-1,349
-230
-53
EBIT
-28,777
-28,777
-27,357
-20,963
-16,785
EBITDA
-28,431
-28,431
-27,057
-20,657
-16,502
Reconciled Depreciation
346
346
300
306
283
Net Income from Continuing Operation Net Minority Interest
-30,944
-30,944
-28,730
-21,194
-16,944
Total Unusual Items Excluding Goodwill
-
-
-
-
-
Total Unusual Items
-
-
-
-
-
Normalized EBITDA
-28,431
-28,431
-27,057
-20,657
-16,502
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0